118 filings
8-K
XBIO
Xenetic Biosciences Inc
22 Mar 24
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results
8:00am
8-K
XBIO
Xenetic Biosciences Inc
12 Feb 24
Regulation FD Disclosure
9:15am
8-K
XBIO
Xenetic Biosciences Inc
8 Dec 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
XBIO
Xenetic Biosciences Inc
13 Nov 23
Xenetic Biosciences, Inc. Reports Third Quarter 2023 Financial Results
8:30am
8-K
XBIO
Xenetic Biosciences Inc
11 Aug 23
Xenetic Biosciences, Inc. Reports Second Quarter 2023 Financial Results
8:05am
8-K
dyuy9lkgz6eghkdqmsyt
6 Jun 23
Regulation FD Disclosure
8:00am
8-K
gg565tp2gytd2t
2 Jun 23
Other Events
8:00am
8-K
kmav6ses
12 May 23
Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock
12:30pm
8-K
grbugwa f0tb9wl99
11 May 23
Xenetic Biosciences, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
4:31pm
8-K
a486ngqnwwpo40ypm
23 Mar 23
Xenetic Biosciences, Inc. Reports Full Year 2022 Financial Results and Provides Business Update
7:30am
8-K
ezipxr1 7y4bk
22 Dec 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
pi7uquu
9 Dec 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
0js88dqwe
2 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
gh9cd
10 Nov 22
Xenetic Biosciences, Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
7:05am
8-K
l1hn9
12 Oct 22
Unregistered Sales of Equity Securities
5:00pm
8-K
m7x7xb9
12 Aug 22
Results of Operations and Financial Condition
8:00am
8-K
5l5xr8ltw7 z3l7dl1
7 Jul 22
Xenetic Biosciences, Inc. Engages Catalent for Clinical Manufacturing to Advance DNase-Based Oncology Platform Towards Phase 1 Study
9:00am
8-K
vocc8u4
6 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
1q2w3omv16is
27 Apr 22
Xenetic Biosciences, Inc. Expands Oncology Pipeline with In-Licensing of DNase Based Oncology Platform Comprising Multiple Therapeutic Modalities
6:30am
8-K
xm3jcw
23 Mar 22
Xenetic Biosciences, Inc. Reports Full Year 2021 Financial Results and Provides Business Update
8:30am